1. Background/introduction {#sec0005}
==========================

The thymoma is the most common tumour of the anterior mediastinum. For its staging, several classifications were developed, and the most accepted and used, is the Masaoka-Koga. In this system the tumour is encapsulated and there is no invasion in stage I; in stage II there is invasion of the mediastinal fat or pleural or micro invasion into the capsule; in stage II the invasion reaches the pericardium, the great vessels or the lungs; and in stage IV there is metastatic spread (pericardial or pleural -- IV A; to the distant through circulatory system -- IV B) [@bib0005].

If there are no distant metastasis, the best treatment is surgery; but due to the invasion of structures such as pleura, lung, trachea, pericardium, heart and great vessels, the Masaoka-Koga stage IV thymoma is very difficult to treat. In these cases, it is recommended neo adjuvant therapy (usually chemotherapy and radiotherapy) and, if possible, a radical surgical resection. With treatment long-term survival improves although a stage IV remains shortened when compared to early-stage disease [@bib0010], [@bib0015].

Here we report a case of a patient with a stage IV thymoma treated with chemotherapy and then by a radical resection with a pleuropneumonectomy, through median sternotomy.

2. Case presentation {#sec0010}
====================

A 58-year-old woman, with no relevant medical history, was presented with retrosternal discomfort (with 2 years of evolution), sporadic dysphagia to solids (with months of evolution) and more recently left cervical swelling.

Chest X-ray findings suggested the presence of a mediastinal mass and a computer tomography (CT) scan revealed a bulky mass (16 × 8, 5 × 8 cm) in the anterior mediastinum, drifting to the left hemithorax, with locoregional infiltrative extension to pericardium and left pleura, with a SUV 12.54 in the PET-Scan and 3 thickenings of the left pleura, also hipermetabolic (SUV 12.39, 10.05, 8.41). Histopathologic analysis of a CT-guided percutaneous core biopsy specimen was compatible with the diagnosis of lymphoma T type leukemia/lymphoblastic lymphoma. Since the subsequent hematologic study excluded lymphoproliferative disease, a new CT-guided percutaneous core biopsy specimen (that came inconclusive) and a biopsy specimen obtained by minithoracotomy, allowed the diagnosis of type B2 thymoma, in a Masaoka-Koga stage IV B.

Three cycles of systemic chemotherapy with cisplatin, cyclophosphamide, and doxorubicin were administered according to institution protocols.

A new CT and PET scan demonstrated a reduction in size and metabolic activity of the mediastinal tumour (6 cm in the major diameter and SUVmax of 6) and a greater response of the pleural thickenings, now with a single irregular thickening (47 × 19 mm, SUVmax 4.5). The patient simple lung function tests were normal ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1A -- Chest CT scans showing a large mediastinal tumour protruding and invading the left hemithorax, with pleural masses in the wall of the same hemithorax.B -- Chest CT scans showing the regression of the mediastinal tumour and pleural masses after three cycles of systemic chemotherapy.

Following a careful clinical assessment, a radical resection was proposed. Due to the size of the tumour and suspicion of an invasion of the hilum of the left lung (including the main pulmonary artery), an approach by median sternotomy was chosen.

After the median sternotomy, and as suspected, we found that the mediastinal tumour involved the pericardium and the hilum of the left lung, and also a great portion of pulmonary parenchyma. The aorta was not involved and the pulmonary artery was easily dissected from the tumour. The thymoma was resected, along with the left part of the pericardium and the left lung. The pleural thickening, in the chest hall, was also resected. The pericardium was reconstructed with a synthetic patch (Parietex, Covidien) ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 2 A -- Thymoma and the left lung, resected together.B -- Open chest by sternotomy, after resection of the thymoma, left lung and annex pericardium. The pericardium was reconstructed with a synthetic patch.

Total Surgical operating time was 150 min.

The postoperative course was long but straightforward, with no major complication, and the patient was discharged 11 days after surgery.

The histological results confirmed a type B2-B3 thymoma, with lung, pleural and vascular invasion, with lymph node from the hilum and surgical margins free from tumour; the pleural thickening was confirmed to be a metastasis.

After the surgery the patient was referred to oncology, with indication for adjuvant chemo and radiotherapy.

3. Discussion {#sec0015}
=============

The optimal treatment for a Masaoka-Koga stage IV thymoma, has not been established yet. Treatments with induction chemotherapy and/or radiotherapy (which increase the rate of complete resection by regressing an unresectable tumour into a resectable one) followed by a radical resection have shown good overall survival rates. Sometimes, even with induction chemotherapy, it is impossible to separat the tumour from the lung, because of invasion of the hilum. In these cases, if the patient pulmonary status allows it, an aggressive approach with *en bloc* mediastinal thymoma resection and pleuropneumonectomy is the only option for a complete resection. Several reports of such approach have been published, with good short-term results [@bib0015], [@bib0020], [@bib0010], [@bib0025].

This case is very interesting from a surgical point of view. The massive invasion of the lung and pleura usually recommend a postero-lateral thoracotomy, but in this case, we needed a safe dissection of the aorta, supra aortic vessels and pulmonary artery, which was not possible with such an approach. Therefore, we decided to operate through a median sternotomy. After sternotomy, we opened the invaded pericardium and we verified that the aorta was not invaded and the main pulmonary artery was easily dissected from the tumour; but the left lung was completely invaded and it was necessary to perform a pneumonectomy. The problem of a left pneumonectomy, by sternotomy, is that the pulmonary vessels are under the heart and the surgical access is difficult. Therefore, the isolation of the pulmonary vessels must be intrapericardic, and for that it is necessary to move the heart anteriorly and to the right. We first dissected and cut the pulmonary vessels and then the left main bronchus.

Here, we demonstrated that an *en bloc* mediastinal thymoma resection and pleuropneumonectomy can be safely achieved using only a median sternotomy approach. The median sternotomy allows not only the safe dissection of the aorta, supra aortic vessels and pulmonary artery, but also the isolation of the pulmonary vessels in the pericardium and the main bronchus. The pleural resection can be easily achieved by using video or a retractor normally used in the harvest of the internal mammary.

4. Conclusion {#sec0020}
=============

The approach to a large and infiltrative thymoma (Masaoka-Koga stage IV) is still unclear. The radical surgery combined with chemo and, eventually, radiation therapy seems to offer the best results, when feasible.

A median sternotomy approach, although difficult, allows complete resection of the mediastinal tumour, along with pneumonectomy and pleurectomy, when necessary, avoiding a second incision (namely, a thoracotomy). This way the recovery is less painful and critical lung function is preserved [@bib0030].
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